SCHEMBL7793537

SCHEMBL7793537

CCN(C)CCOC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11154206 0.86 KDM5A (0.33)
SCHEMBL2962393 0.79 CA12 (0.50)
SCHEMBL17401242 0.79 CA12 (0.32)
SCHEMBL789797 0.78 KMT2A (0.45)
SCHEMBL22294054 0.77
SCHEMBL425201 0.77
SCHEMBL7489795 0.77 S1PR2 (0.46)
SCHEMBL6199544 0.77 S1PR2 (0.46)
Hydrochloric Acid SCHEMBL3205113 0.76 KMT2A (0.43)
SCHEMBL25828235 0.76 PIK3CD (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9968589-B2 Method of treating disease by auricular anesthesia of cranial nerves CREWS THOMAS M (US) 2018-05-15 US disclosed
US-20010001101-A1 Phenanthroline derivatives ZENECA LIMITED 2001-05-10 US disclosed
EP-1027351-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 2000-08-16 EP disclosed
US-5916898-A ANTIFIBROPROLIFERTIVE, ENZYME INHIBITORS OF PYROLYL 4-HYDROXYLASE, ANTIARTHRITIC AGENTS ZENECA LIMITED (GB) 1999-06-29 US disclosed
WO-1999021860-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 1999-05-06 WO disclosed